NCT07166770

Brief Summary

The goal of this adapted intervention study is to assess how community-led group discussions about health-related topics may alter beliefs and intentions regarding healthcare recommendations, such as COVID-19 testing and vaccination.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable covid19

Timeline
Completed

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 5, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 10, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 27, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 27, 2026

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

7 months

First QC Date

September 5, 2025

Last Update Submit

February 25, 2026

Conditions

COVID-19Trust

Keywords

community-ledCOVID-19trustvaccine hesitancypeer mentorcommunity advisory board

Outcome Measures

Primary Outcomes (3)

  • Openness to COVID-19 Testing

    The COVID-19 Testing Openness Questionnaire is an 7-item self-report measure designed to assess participants' openness to getting tested for COVID-19. Each item is rated on a 5-point scale, from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging from 7 to 35. Higher scores indicate greater openness to COVID-19 testing.

    0 weeks, 14 weeks, 18 weeks

  • COVID-19 Testing Efficacy

    The COVID-19 Testing Efficacy Scale is a 6-item self-report measure that will assess participants' perceived self- and response-efficacy related to COVID-19 testing. Each item is rated on a 5-point scale ranging from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging between 6 and 30. Higher scores indicate greater efficacy.

    0 weeks, 14 weeks, 18 weeks

  • COVID-19 Trust

    Two items assessing (1) trust in the safety of the COVID-19 vaccine, and (2) trust in the efficacy of the COVID-19 vaccine were used to assess participants' trust relating to COVID-19. Each item is rated on a 5-point Likert scale. Higher scores indicate greater trust.

    0 weeks, 14 weeks, 18 weeks

Secondary Outcomes (3)

  • COVID-19 Vaccine Hesitancy

    0 weeks, 14 weeks, 18 weeks

  • Social Connectedness

    0 weeks, 14 weeks, 18 weeks

  • Health Literacy

    0 weeks, 14 weeks, 18 weeks

Study Arms (2)

Control

NO INTERVENTION

non-intervention control (participants complete surveys only)

Intervention

EXPERIMENTAL

Participants engage in weekly community-led small group discussions about health-related topics and answer surveys at 0, 14, and 18 week time points

Behavioral: Community-led discussion

Interventions

Community-led discussionBEHAVIORAL

Participants engage in weekly community-led small group discussions about health related topics

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Resident of one of the 9 housing authority agencies
  • Willing to participate in Zoom meetings and complete online assessments at baseline, 14-week, and 18-week timepoints
  • Ability to read, speak, and understand English

You may not qualify if:

  • May not have participated in Study 1

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Macon & Joan Brock Virginia Health Institute at Old Dominion University

Norfolk, Virginia, 23507, United States

Location

MeSH Terms

Conditions

COVID-19Vaccination Hesitancy

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesVaccination RefusalTreatment RefusalTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Kelli J England, PhD

    Old Dominion University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants randomly assigned to intervention or control group; repeated measure assessments at 0 weeks, 14 weeks, and 18 weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 5, 2025

First Posted

September 10, 2025

Study Start

July 1, 2025

Primary Completion

January 27, 2026

Study Completion

January 27, 2026

Last Updated

February 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations

US(1)